38 results on '"Rönnelid, Johan"'
Search Results
2. Additional file 3 of Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity
3. Additional file 1 of Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity
4. Additional file 3 of Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity
5. Additional file 3 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
6. Additional file 7 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
7. Additional file 6 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
8. Additional file 6 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
9. Additional file 7 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
10. Additional file 4 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
11. Additional file 1 of The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis
12. Additional file 4 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
13. Additional file 8 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
14. Additional file 8 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
15. Additional file 2: Figure S1. of Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis
16. Additional file 1: Table S1. of Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis
17. Additional file 2: Figure S1. of Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis
18. Additional file 5: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
19. Additional file 1 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
20. Additional file 1: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
21. Additional file 2: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
22. Additional file 5 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
23. Additional file 4: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
24. Additional file 9 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
25. Additional file 1 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
26. Additional file 5 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
27. Additional file 2 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
28. Additional file 5: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
29. Additional file 9 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
30. Additional file 1 of The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual 'window of treatment success' in RA patients
31. Additional file 3: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
32. Additional file 1 of The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual 'window of treatment success' in RA patients
33. Additional file 3: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
34. Additional file 2: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
35. Additional file 6: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
36. Additional file 1: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
37. Additional file 6: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
38. Additional file 4: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.